Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Remde

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Discover Oncology|February 24, 2022
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretionMinghao Li, Christina Pamporaki, Stephanie M J Fliedner, et al.
Clinical Endocrinology|March 8, 2026
Improvement of Health-Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary AldosteronismSybille Fuld, Christian Adolf, Georgiana Constantinescu, et al.
Hypertension (Dallas, Tex. : 1979)|July 31, 2024
Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive DrugsGeorgiana Constantinescu, Sven Gruber, Sybille Fuld, et al.
The Journal of Applied Laboratory Medicine|March 27, 2024
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient StudySybille Fuld, Georgiana Constantinescu, Christina Pamporaki, et al.
Journal of Hypertension|July 24, 2025
The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronismChristina Pamporaki, Hanna Remde, Georgiana Constantinescu, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
The <i>ARRplus</i>: a model for renin-dependent and sex-specific aldosterone cut-offs that improves screening for primary aldosteronismSybille Fuld, Jun Yang, Georgiana Constantinescu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2022
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paragangliomaChristina Pamporaki, Tamara Prodanov, Leah Meuter, et al.
The Journal of Clinical Endocrinology and Metabolism|October 3, 2022
Recurrent Disease in Patients With Sporadic Pheochromocytoma and ParagangliomaMinghao Li, Tamara Prodanov, Leah Meuter, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
European Journal of Endocrinology|June 26, 2025
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapyIsabel Weigand, Alexandra S Triebig, Tanja Maier, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Discover Oncology|February 24, 2022
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretionMinghao Li, Christina Pamporaki, Stephanie M J Fliedner, et al.
Clinical Endocrinology|March 8, 2026
Improvement of Health-Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary AldosteronismSybille Fuld, Christian Adolf, Georgiana Constantinescu, et al.
Hypertension (Dallas, Tex. : 1979)|July 31, 2024
Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive DrugsGeorgiana Constantinescu, Sven Gruber, Sybille Fuld, et al.
The Journal of Applied Laboratory Medicine|March 27, 2024
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient StudySybille Fuld, Georgiana Constantinescu, Christina Pamporaki, et al.
Journal of Hypertension|July 24, 2025
The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronismChristina Pamporaki, Hanna Remde, Georgiana Constantinescu, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2026
The <i>ARRplus</i>: a model for renin-dependent and sex-specific aldosterone cut-offs that improves screening for primary aldosteronismSybille Fuld, Jun Yang, Georgiana Constantinescu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2022
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paragangliomaChristina Pamporaki, Tamara Prodanov, Leah Meuter, et al.
The Journal of Clinical Endocrinology and Metabolism|October 3, 2022
Recurrent Disease in Patients With Sporadic Pheochromocytoma and ParagangliomaMinghao Li, Tamara Prodanov, Leah Meuter, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
European Journal of Endocrinology|June 26, 2025
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapyIsabel Weigand, Alexandra S Triebig, Tanja Maier, et al.
Pageof 5